Inmune Bio, Inc. - COM (INMB)

Historical Portfolio Holders from Q1 2019 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
2.74 M
Holdings value Q1 2024
$32.2 M
Value change Q1 2024
+$5.31 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
49
Number of buys Q1 2024
2
Number of sells Q1 2024
0
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0
CUSIP
45782T105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 34.4 K $303 K +$23.7 K $8.11 2
2024 Q1 2.74 M $32.2 M +$5.31 M $11.75 49
2023 Q4 2.29 M $25.8 M +$2.02 M $11.26 46
2023 Q3 2.06 M $14 M +$742 K $6.77 34
2023 Q2 2 M $18.2 M +$1.89 M $9.08 30
2023 Q1 1.8 M $11.7 M +$1.1 M $6.46 31
2022 Q4 1.64 M $10.4 M -$731 K $6.34 30
2022 Q3 1.91 M $11.9 M -$734 K $6.20 29
2022 Q2 1.97 M $17.2 M -$2.44 M $8.84 32
2022 Q1 2.25 M $18.9 M -$2.11 M $8.42 29
2021 Q4 2.47 M $25.2 M +$4.65 M $10.20 40
2021 Q3 1.91 M $37.1 M +$3.94 M $19.42 38
2021 Q2 1.73 M $30.4 M +$8.49 M $17.57 38
2021 Q1 1.3 M $15.5 M +$5.29 M $11.88 30
2020 Q4 853 K $15 M +$1.18 M $17.21 24
2020 Q3 992 K $10.2 M +$6.46 M $10.30 26
2020 Q2 359 K $1.88 M +$105 K $5.17 11
2020 Q1 342 K $1.14 M +$201 K $3.32 9
2019 Q4 282 K $1.64 M +$40.4 K $5.80 9
2019 Q3 275 K $1.62 M +$1.39 M $5.90 9
2019 Q2 38.7 K $375 K -$41 K $9.72 7
2019 Q1 44.9 K $351 K +$351 K $7.64 4